214 related articles for article (PubMed ID: 22874488)
1. [Psychiatric disorders associated with high-dose methadone (>100 mg/d): a retrospective analysis of treated patients].
Eiden C; Leglise Y; Clarivet B; Blayac JP; Peyrière H
Therapie; 2012; 67(3):223-30. PubMed ID: 22874488
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of long QTc interval in methadone maintenance patients.
Fonseca F; Marti-Almor J; Pastor A; Cladellas M; Farré M; de la Torre R; Torrens M
Drug Alcohol Depend; 2009 Jan; 99(1-3):327-32. PubMed ID: 18774239
[TBL] [Abstract][Full Text] [Related]
3. Depression in methadone maintenance treatment patients: rate and risk factors.
Peles E; Schreiber S; Naumovsky Y; Adelson M
J Affect Disord; 2007 Apr; 99(1-3):213-20. PubMed ID: 17055063
[TBL] [Abstract][Full Text] [Related]
4. Documented poor sleep among methadone-maintained patients is associated with chronic pain and benzodiazepine abuse, but not with methadone dose.
Peles E; Schreiber S; Adelson M
Eur Neuropsychopharmacol; 2009 Aug; 19(8):581-8. PubMed ID: 19411166
[TBL] [Abstract][Full Text] [Related]
5. 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel.
Peles E; Schreiber S; Adelson M
Drug Alcohol Depend; 2010 Mar; 107(2-3):141-8. PubMed ID: 19914783
[TBL] [Abstract][Full Text] [Related]
6. Patient satisfaction with methadone maintenance treatment: the relevance of participation in treatment and social functioning.
Trujols J; Garijo I; Siñol N; del Pozo J; Portella MJ; Pérez de los Cobos J
Drug Alcohol Depend; 2012 Jun; 123(1-3):41-7. PubMed ID: 22071121
[TBL] [Abstract][Full Text] [Related]
7. Different patterns of sexual dysfunctions associated with psychiatric disorders and psychopharmacological treatment. Results of an investigation by semistructured interview of schizophrenic and neurotic patients and methadone-substituted opiate addicts.
Teusch L; Scherbaum N; Böhme H; Bender S; Eschmann-Mehl G; Gastpar M
Pharmacopsychiatry; 1995 May; 28(3):84-92. PubMed ID: 7568370
[TBL] [Abstract][Full Text] [Related]
8. Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy.
Roy AK; McCarthy C; Kiernan G; McGorrian C; Keenan E; Mahon NG; Sweeney B
Addiction; 2012 Jun; 107(6):1132-9. PubMed ID: 22168435
[TBL] [Abstract][Full Text] [Related]
9. The impact of benzodiazepine use on methadone maintenance treatment outcomes.
Brands B; Blake J; Marsh DC; Sproule B; Jeyapalan R; Li S
J Addict Dis; 2008; 27(3):37-48. PubMed ID: 18956528
[TBL] [Abstract][Full Text] [Related]
10. [Influence of psychiatric disorders in the effectiveness of a long-term methadone maintenance treatment].
Fernández Miranda J; González García-Portilla M; Sáiz Martínez P; Gutiérrez Cienfuegos E; Bobes García J
Actas Esp Psiquiatr; 2001; 29(4):228-32. PubMed ID: 11470057
[TBL] [Abstract][Full Text] [Related]
11. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
[TBL] [Abstract][Full Text] [Related]
12. Methadone maintenance and male sexual dysfunction.
Brown R; Balousek S; Mundt M; Fleming M
J Addict Dis; 2005; 24(2):91-106. PubMed ID: 15784526
[TBL] [Abstract][Full Text] [Related]
13. High dose versus moderate dose methadone maintenance: is there a better outcome?
Fareed A; Casarella J; Roberts M; Sleboda M; Amar R; Vayalapalli S; Drexler K
J Addict Dis; 2009 Oct; 28(4):399-405. PubMed ID: 20155609
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting the outcome of methadone maintenance treatment in opiate dependence.
Kamal F; Flavin S; Campbell F; Behan C; Fagan J; Smyth R
Ir Med J; 2007 Mar; 100(3):393-7. PubMed ID: 17491538
[TBL] [Abstract][Full Text] [Related]
15. Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention.
White WL; Campbell MD; Spencer RD; Hoffman HA; Crissman B; DuPont RL
J Psychoactive Drugs; 2014; 46(2):114-22. PubMed ID: 25052787
[TBL] [Abstract][Full Text] [Related]
16. Methadone dosage and retention: an examination of the 60 mg/day threshold.
Brady TM; Salvucci S; Sverdlov LS; Male A; Kyeyune H; Sikali E; DeSale S; Yu P
J Addict Dis; 2005; 24(3):23-47. PubMed ID: 16186081
[TBL] [Abstract][Full Text] [Related]
17. A national study of the retention of Irish opiate users in methadone substitution treatment.
Mullen L; Barry J; Long J; Keenan E; Mulholland D; Grogan L; Delargy I
Am J Drug Alcohol Abuse; 2012 Nov; 38(6):551-8. PubMed ID: 22747484
[TBL] [Abstract][Full Text] [Related]
18. Duration of methadone maintenance treatment during pregnancy and pregnancy outcome parameters in women with opiate addiction.
Peles E; Schreiber S; Bloch M; Dollberg S; Adelson M
J Addict Med; 2012 Mar; 6(1):18-23. PubMed ID: 21817914
[TBL] [Abstract][Full Text] [Related]
19. Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence.
Karow A; Reimer J; Schäfer I; Krausz M; Haasen C; Verthein U
Drug Alcohol Depend; 2010 Dec; 112(3):209-15. PubMed ID: 20728288
[TBL] [Abstract][Full Text] [Related]
20. HIV infection as a predictor of methadone maintenance outcomes in Chinese injection drug users.
Zhao L; Holzemer WL; Johnson M; Tulsky JP; Rose CD
AIDS Care; 2012; 24(2):195-203. PubMed ID: 21780984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
